The data sheet of May 1998 states "No clinically significant tachycardia, hypotension or other clinical signs of histamine release associated with the administration of Esmeron ® have been reported". Recently it has been suggested that histaminoid reactions to rocuronium at induction might occur with an incidence of 1 in 3000 1 . We present this well documented allergic reaction to rocuronium.
A 62-year-old woman of 94 kg was undergoing hysterectomy for persistent cervical dyskaryosis. General anaesthesia without muscle relaxation for previous gynaecological procedures had twice been uneventful.
After premedication with diazepam 10 mg and metoclopramide 10 mg, heart rate was 73 bpm, and NIBP 134/65 mmHg. Anaesthesia was induced with ondansetron 4 mg, alfentanil 1 mg, propofol 200 mg and rocuronium 50 mg, while a bolus of 11 mg morphine was then infused from a PCAS. After laryngoscopy and tracheal intubation with an 8 mm cuffed tube, the patient developed marked bronchospasm and hypotension (46/25 mmHg) together with an erythematous rash. Treatment with IV adrenaline 1:10000 (5 x 1 ml) and hydrocortisone 200 mg stabilized the situation and after the administration of chlorpheniramine 10 mg and the insertion of a radial artery cannula to facilitate monitoring it was eventually decided to proceed with surgery while ICU transfer was being organized. After elective overnight BIPAP ventilation, during which time KCl 140 mmol was needed to correct potassium from 2.7 to 4.4 mmol/l, the patient was safely discharged to the ward. Measurements of tryptase showed a normal basal level with a rise consistent with mast cell degranulation.
*Subsequent skin prick testing showed a positive reaction to rocuronium at 1:100 dilution (3 mm wheal and 10 mm flare) but no reaction to atracurium or propofol while intradermal testing of morphine 1:100000 and alfentanil 1:100 was also negative. The first patient of this series has been published as a case report (see Reference 3).
Jehovah's Witnesses refuse any blood transfusions. Strict Witnesses even refuse the use of conventional autotransfusion devices because the continuity of blood is not maintained 1 . New technology, however, maintains the continuity of blood 2, 3 . We here describe the use of such a device (CATS) in eight consecutive Witnesses undergoing open heart surgery.
After termination of the extracorporeal circulation, the inflow port of the extracorporeal circuit was removed. The aortic cannula was kept in place and was used for retransfusion until the patient would not tolerate any more volume. Blood remaining in the reservoir, the oxygenator and the tubings was then processed by the CATS. As soon as processed blood was available, it was retransfused through a cannula previously inserted into the lower limb, and the aortic cannula was then removed.
The CATS processed 1230±123 ml with a haematocrit of 23±1% and delivered 356±44 ml of washed blood with a haematocrit of 78±4%. The patients' haematocrit rose from 23±1% to 32±2%.
The CATS allows for autotransfusion even in strict Witnesses. The obtained rise in haematocrit serves to prevent an oxygen debt and reduces the perioperative risk.
After surgery of high emetogenic potential, both total intravenous anesthesia (TIVA) and prophylactic antiemetic therapy reduce the incidence of postoperative nausea and vomiting.
We studied 144 patients scheduled for day-case gynaecological laparoscopy in a randomized, blinded trial, comparing balanced inhalational anaesthesia and prophylactic dolasetron (group BD) with TIVA and dolasetron (group PD) or TIVA alone (group P).
The primary endpoint of complete response (no vomiting, no treatment for PONV) was not significantly different between groups (34%, 51%, 32%; groups BD vs PD vs P, P=0.12). During the first postoperative hour, group BD had more nausea and nausea and it was of greater severity (P<0.03). While in hospital, group P had more vomiting (P<0.03). From discharge until 24 hours postoperatively, group BD had greater nausea and lower patient satisfaction (P<0.04). Although several secondary endpoints were lowest in group PD, when compared with group P, only the incidence and severity of nausea following hospital discharge was significant lower (P<0.03)
In conclusion, we found that TIVA, with or without dolasetron, reduced postoperative nausea, but not vomiting or antiemetic requirement, when compared with inhalational anaesthesia. Recovery from anaesthesia may be different for men and women. We have analysed data from a recent trial investigating several anaesthetic regimens to examine the impact of gender on measures of postoperative outcome.
After ethics committee approval and informed consent, patients were randomly allocated to one of four groups: 1. thiopentone induction, followed by isoflurane maintenance; 2. propofol induction, followed by isoflurane maintenance; 3. propofol TIVA; or 4. sevoflurane induction and maintenance. Speed of recovery, QoR scores and rates of predetermined complications were recorded. Postoperative follow up was for three days. Sample size was predetermined to give 80% overall power. Data were analysed using x 2 , t test, or U test.
A total of 239 men and 222 women were recruited. Both groups were comparable for age, ASA status and duration of surgery. Speed of recovery was significantly faster in women for time to eyeopening (P=0.011) and obeying commands (P=0.001). Overall quality of recovery (QoR score) was worse in women (P=0.02). Specifically, women had a higher incidence of PONV on all days (P<0.001, risk ratio=1.5 on day 0, to 2.0 on day 3). Postoperative headache was more common on day 2 (P=0.003, risk ratio=1.5), and backache on day 1 (P=0.003, risk ratio=1.5).
This prospective study confirms previous retrospective observations that women recover more rapidly from anaesthesia, but afterwards, report complications more commonly than men. These complications are traditionally termed "minor" but are frequent recollections of anaesthesia. More information is needed on the effects of anaesthesia in females. This will make postoperative outcome studies more meaningful, and may help improve women's recovery from anaesthesia. We aimed to survey all consultant ("attending") surgeons, including obstetrician/gynaecologists, in the state of Western Australia (W.A.) to assess their experience with and readiness to assist anaesthetists with a difficult or failed airway.
Four hundred and forty-five survey questionnaires were mailed to all surgeons registered with their respective Colleges and Societies in W.A.
Within one week of the mail-out, 117 responses had been received. Sixty-four per cent of surgeons had not performed an elective surgical airway in the preceding 12 months and 20% had never performed tracheostomy. Forty-three percent had assisted an anaesthetist with a difficult airway in a nonsurgical capacity, 64% had performed an emergency surgical airway and 58% had been witness to an anaesthetist dealing with an airway crisis where the patient was awakened or a surgical airway was used. When asked whether they (the surgeon) felt confident in providing an urgent surgical airway, 28% answered that they did not feel confident. Five per cent of surgeons had witnessed a patient who died or suffered neurological damage. Finally, 77% of respondents had undergone training in tracheostomy and 27% had ATLS or EMST training but 23% had received no such training.
Consultant surgeons performed tracheostomy/surgical airways infrequently and occasionally assisted anaesthetists with difficult airways. Many surgeons were not confident in providing surgical airway if an anaesthetist required urgent assistance. Anaesthetists cannot always rely on their surgical colleagues for provision of a surgical airway during a crisis. These results have implications for anaesthesia training. The Factor V (FV) Leiden mutation results in activated protein C (APC) resistance and is the most common hereditary thrombophilic disorder. The risk of venous thrombosis is increased up to sevenfold in heterozyotes and eightyfold in homozygotes. The APC ratio, a coagulation based assay, is low in subjects with APC resistance and indicates a predisposition to thrombosis. Aprotinin is an inhibitor of APC and thus may result in a greater predisposition to thrombosis if given to FV Leiden patients.
The study aimed to assess the effect of aprotinin on normal and FV Leiden blood in an ex vivo cardiopulmonary bypass (CPB) model.
A CPB model consisting of roller pump, oxygenator, arterial line filter and circuitry was constructed and primed with Ringers lactate. Blood 480ml was venesected into a CPD bag. Four treatments were undertaken: A. Normal blood and aprotinin. B. Normal blood and saline. C. FV Leiden blood and aprotinin. D. FV Leiden blood and saline.
Aprotinin or saline, and heparin were added to the blood bag before placement in the oxygenator reservoir. The blood was circulated for 65 minutes. Protamine was then given in 10 mg bolus doses at five-minute intervals until clotting occurred. Blood was sampled for assessment of APC ratio at the following times: from CPD bag before and after aprotinin or saline and after heparin, from circuit at 15 minute intervals until protamine and then at five-minute intervals until clotting.
There was a decrease in APC ratio for both FV Leiden and normal bloods following the addition of aprotinin. The lowest APC ratio was detected in Treatment Group C (0.62), followed by D (0.715), A (0.93) and B (1.28). Reference range (1.9-4.0).
Aprotinin, when added to FV Leiden blood, will decrease the APC ratio to an extremely low abnormal value which in the clinical setting may result in an increased risk of thrombosis. Clotting in the oxygenator and coronary graft thrombosis may be possible adverse outcomes. We aimed to determine the effect of the MRI / NMR environment upon the function and accuracy of drug delivery by Graseby 3500 syringe pumps.
The study was designed to show equivalence (i.e., no difference in performance). Sample size were calculated accordingly. Five separate Graseby 3500 pumps were examined. Five sequential replicate samples for each pump were taken. (Collected at threeminute intervals whilst programmed to deliver 60 ml/hour.) Each sample was examined gravimetrically. The above was performed on two separate occasions:
Control : performed distant and prior to MRI exposure MRI: performed inside the MRI suite during an actual MRI patient scan-pumps were placed two metres from the opening of a Siemans 1.5 Tesla scanner where the static magnetic field strength was measured at 5 Gauss.
Statistical Methods: A difference in infusion of 0.04 g was defined to show equivalence in this study. Generalized linear models with random effects were used to analyse the data with repeated measurements. Bland and Altman's method was used to assess agreement between Control and MRI phase. All analysis was done using SAS software.
The average infusion during Control phase was 2.94 g (SD= 0.010) compared to MRI with a mean of 2.96 (SD=0.009). Overall there is no significant difference between the mean infusion during the Control phase and MRI phase (P=0.165). Infusion was slightly higher during MRI (mean difference of 0.025 g) compared to Control, which is not statistically significant. This was within our definition of equivalence.
Our study shows that MRI does not significantly effect function and delivery of the Graseby 3500 ( "Diprifusor" ) syringe pump system when programmed and used at 2 metres or within a 5 Gauss environment. Doppler Tissue Imaging (DTI) directly measures the movement of the myocardium over the cardiac cycle, and is commonly measured at the mitral annulus. DTI results have been commonly described using transthoracic echocardiography (TTE), but the technique has not been validated using TOE. This study was undertaken to assess the correlation of TOE versus TTE assessment of mitral annular wall motion.
COMPARISON OF TRANSOESOPHAGEAL DTI OF
Eleven consecutive patients were referred for TOE assessment either for atrial arrhythmia or patent foamen ovale. We performed TTE within two hours (and generally within 30 minutes) of performing a TOE. DTI signals of mitral annular motion wre obtained measuring systolic velocity (S), early (E`) and late (A`) velocities.
There was a good correlation between TTE and TOE measured mitral annulus motion. A high level of correlation using a paired t-test was seen for the S wave (P=0.011), E wave (P=0.014) and A wave (0.004).
DTI using TOE correlates with TTE measurements obtained and is an accurate tool to measure myocardial velocities. From the results of this study it can be inferred that TOE is an equivalent measure to TTE for tissue Doppler at the mitral annulus, for both the systolic and diastolic components of wall movement. Traditional treatment of atrial arrhythmias involves cardioversion after exclusion of left atrial thrombus. These procedures are traditionally performed by different clinicians-often in different places on different days.
The aim of this study was to develop a new technique of combined TOE and cardioversion under a single sedation technique for patients with chronic atrial arrhythmias.
Twenty-seven consecutive patients with atrial fibrillation (22), atrial flutter (3) and atrial tachycardia (2) referred for TOE examination were enrolled for this pilot study to perform the procedure as a single technique. TOE was performed in 22 patients (five cases spontaneously reverting to sinus rhythm) and cardioversion performed in 21 patients (one case of left atrial thrombus detected). Sedation was commenced after topical anaesthesia using lignocaine with an IV bolus of fentanyl and propofol, and maintained with a propofol infusion. After exclusion of left atrial thrombus immediate synchronized cardioversion was performed.
The duration of the combined procedure lasted for 30 to 40 minutes and there were no complications. Recovery from sedation was rapid and allowed neurological assessment prior to discharge. Using this technique a reduction in the number of episodes requiring sedation, inpatient stay and cost whilst improving patient comfort.
Combined TOE and cardioversion is a feasible technique that demonstrates improved patient comfort with a reduction in cost and time. Until now, intraoperative autotransfusion (IAT) has been contraindicated if the blood volume to be processed is below 300 ml 1 . Smaller volumes cannot be effectively washed and haemoconcentrated by available autotransfusion devices. Given a blood volume of 80 ml/kg, a tolerated blood loss of 40 ml/kg, and the fact that approximately two thirds of the blood loss is usually collected in gauzes and thus is not available for autotransfusion, the minimum body weight of an infant to undergo IAT is 22.5 kg. We investigated in an in vitro setup whether new autotransfusion technology, which has recently become available, allows effective processing smaller blood volumes, and therefore it may be indicated in children of less than 22.5 kg body weight.
Outdated units of PRBC were diluted with saline to a haematocrit of 30%. This solution was then processed using the new continuous autotransfusion device based on cell separator technology (CATS; Fresenius AG, Bad Homburg, FRG). Volumes of 100, 200, 300, and 400 ml were processed 10 times each. The haematocrit of the processed blood unit and the potassium elimination rate (KER) were measured and served as endpoints for haemoconcentration and washout respectively. 
Results
The CATS delivered a constantly high haematocrit and a nearly complete potassium washout, independent of the volume being processed.
The CATS allows for effective washing and haemoconcentration, even in blood volumes as small as 100 ml. Given the above criteria (blood volume of 80 ml/kg, tolerated blood loss of 40 ml/kg, and 50% of the blood loss available for autotransfusion), the CATS allows for IAT in children with a body weight of 7.5 kg. Considering that small children are the patients which profit most from a prevented hepatitis or HIV infection as well as from prevented life-long lasting immunologic reactions, the CATS is a useful tool in achieving this goal. The effect of noradrenaline on the cerebral vasculature of healthy awake individuals is unclear. Previous work using noradrenaline in awake patients did not differentiate between the effects of noradrenaline and the autoregulatory response to the associated increase in blood pressure. In this study we tested the hypothesis that circulating noradrenaline had a direct cerebrovascular effect in healthy conscious individuals when blood pressure was returned to baseline levels using phentolamine.
Mean arterial pressure (MAP; arterial tonometry) and cerebral blood flow velocity in the middle cerebral artery (CFV) (transcranial Doppler) were measured in eight healthy individuals during 15-minute periods of saline and of 50 (LOW NA) and 100 (HIGH NA) ng/kg/min noradrenaline. Following this, phentolamine was administered to return blood pressure back to baseline, while the noradrenaline infusion was maintained (NA+PH). Finally, the noradrenaline infusion was stopped while phentolamine effects continued (PH).
Circulating noradrenaline caused a significant increase in MAP (P<0.001). CFV remained constant during the LOW and HIGH noradrenaline infusion even with the increased pressure due to a significant increase in cerebral vascular resistance (CVR= MAP/CFV; P<0.005). The increased CVR was eliminated during NA+PH. However, CFV became significantly elevated once noradrenaline infusion was stopped but phentolamine continued (P<0.05).
CVR increased during noradrenaline infusions but was reduced to baseline levels when phentolamine reduced the hypertensive effects of continued noradrenaline infusions (i.e., the first data point in the NA+PH segment). Therefore, the increase in CVR during noradrenaline infusions was associated with the increased blood pressure, suggesting an autoregulatory response. We con-clude that noradrenaline infusion in healthy awake individuals does not exert direct cerebrovascular effects.
This study was supported by the Natural Previous studies using pregnant animal models have shown that maternal psychological stress results in adverse intrauterine conditions for the fetus. It is postulated that methods of reducing maternal anxiety are not only humane but also improve conditions for the fetus.
The object of our study was to investigate anxiety levels in patients undergoing elective caesarean section under regional anaesthesia, and to ascertain whether this group of patients considered the administration of anxiolytic premedicant drugs prior to surgery acceptable.
Anxiety was assessed in two ways, using a self-reported score on a visual analog scale and a physiological evaluation in the form of skin conductance measurements. The patient's opinion on the use of anxiolytic premedicant drugs before caesarean section was determined using a questionnaire. Prior to its completion, the patient was asked to read an information sheet explaining the potential advantages and disadvantages associated with the use of temazepam as an anxiolytic premedicant in this context.
Thirty-five patients took part in the study and most women reported high preoperative anxiety levels (Figure 1 ). Despite being aware of the potential adverse side effects of temazepam premedication in the obstetric setting, fifteen patients (43%) stated that if they had been offered it prior to their caesarean section, they would have accepted it. Their reasons included wishing to be more relaxed and believing that being more relaxed could be of benefit to their baby.
Figure 1
Anxiety VAS score for each timepoint (timepoint 1: at preoperative assessment, timepoint 2: immediately prior to commencement of regional anaesthesia, timepoint 3: postoperatively). The error bars represent 2 x standard error of the mean.
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